None listed
Conditions
Brief summary
Insomnia is a common reason for purchasing complementary remedies in pharmacy or seeking advice in pharmacy. However, it may indicate an underlying problem. There is no comprehensive screening tool that has been developed for pharmacy use to ascertain where insomnia may be secondary to another cause (e.g. depression, sleep apnoea). A short screening tool that has been validated in general practice in NZ will be adapted and used in pharmacy. We will look for workability of the tool for the pharmacist (how long it takes, how useful it is), findings of the questionnaire (compared to the gold-standard questionnaire), frequency of medical referral. We will compare the outcomes of the questionaire with the gold standard 7-page questionnaire. Consumers presenting in the pharmacy for a sleep remedy or for advice on insomnia for themselves will do the short 2-page questionnaire with the pharmacist. The pharmacist will provide advice e.g. on sleep hygiene or medical referral based on this questionnaire and their expertise. The participant will self -complete the 7-page questionnaire for return to the researchers. The pharmacist will follow up the participant after 2 weeks to ascertain what (if any) action was taken by the participant, the outcomes of this action (e.g. new diagnosis by the doctor), and whether sleep was thought to have improved, worsened or stayed the same.
Interventions
Pharmacists who have completed the Goodfellow training on Insomnia will use a screening tool (the adapted 2-page short Auckland Sleep Questionnaire developed by Arroll, Fernando and Falloon) and provide advice in the pharmacy including medical referral for people presenting with insomnia. This will take place face-to-face. The questionnaire has been adapted for pharmacy use by Arroll and Gauld following feedback from pharmacists and doctors. Medical referral is as per this sleep questionnaire wh
Pharmacists who have completed the Goodfellow training on Insomnia will use a screening tool (the adapted 2-page short Auckland Sleep Questionnaire developed by Arroll, Fernando and Falloon) and provide advice in the pharmacy including medical referral for people presenting with insomnia. This will take place face-to-face. The questionnaire has been adapted for pharmacy use by Arroll and Gauld following feedback from pharmacists and doctors. Medical referral is as per this sleep questionnaire which has clear referral points for possible underlying concerns affecting sleep (with input from doctors). The pharmacist would run through their consultation with a person with insomnia guided by this tool, noting answers to questions. Participants would then self-complete in a private room in the pharmacy the full validated 7-page Auckland Sleep Questionnaire (from which the short Auckland Sleep Questionnaire was derived) for use by researchers only. The pharmacist would then diagnose primary insomnia or refer to a doctor according to the tool and/or provide advice (e.g. sleep hygiene) as the pharmacist deems appropriate (noting their recent Goodfellow training on Insomnia and undergraduate training in this area and according to the answers the person has given, e.g. drinking caffeine or alcohol). Pharmacists will use their usual referral process, which could involve advising the participant to see their doctor or send a notification to the doctor - this will be at the pharmacist's discretion. The screening tool looks for underlying causes of insomnia, e.g. indications of depression, obstructive sleep apnoea, etc. The pharmacist will ring 2 weeks later to ask what action was taken and what effect it had.
Sponsors
Natalie Gauld Ltd
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Diagnosis
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Adults 18 years and over purchasing a sleep remedy or with trouble sleeping who are in the pharmacy.
Exclusion criteria
Inability to read or understand English Taking prescription medicines for sleep 2 or more nights per week
Outcome results
None listed